Sturnam
Bluelighter
- Joined
- Aug 12, 2008
- Messages
- 738
Recently, I've been talking with someone who has told me that CB2 agonists induce apoptosis of immune cells, specifically T-cells, and that since the thymus is basically done producing T cells at age 14 (IIRC), this can mess with your immune system later in life.
Marijuana has a partial CB2 component, but obviously there isn't any notable immunosuppression, because even heavy users do not develop opportunistic infections. Therefore, any suppression of the immune system is likely 'superficial' and not detrimental to long term health.
My question is regarding the immunosuppressive effects of the 'new' cannabinoids (JWH-018, 073, 250, etc). These compounds are largely full agonists, which means that they will most likely have a greater effect on CB2 mediated apoptosis of T-cells. The person I talked to about this was very insistent that use of these compounds would severely fuck you up, for lack of a better term.
However, some research has determined that these drugs would be beneficial for pain, as well as fighting cancer.
http://www.ncbi.nlm.nih.gov/pubmed/17185040
I personally know of several different trials that are utilizing CB2-selective agonists for a variety of ailments, which to me, hints that these compounds are not as immunosupressive as my friend led me to believe.
Does anyone here have any insight to how detrimental these potent CB agonist could be for the immune system? Is it likely that use of these compounds could produce permanent immune system dysfunction through destruction of T-cells? I understand that I will most likely not get a definitive answer, I'm just looking for someone who has a better understanding of CB2 receptors and the immune system, as well as how 'delicate' the population of T-cells is (i.e. how much destruction of T-cells before noticeable impairments in immune function. For example, Parkinson's symptoms aren't exhibited until >70% neuron loss in the substantia nigra.)
Edit: I realize my example of Parkinson's is not exactly analogous, however, it highlights the issue of distinction between destruction of cells and measurable impairment.
Marijuana has a partial CB2 component, but obviously there isn't any notable immunosuppression, because even heavy users do not develop opportunistic infections. Therefore, any suppression of the immune system is likely 'superficial' and not detrimental to long term health.
My question is regarding the immunosuppressive effects of the 'new' cannabinoids (JWH-018, 073, 250, etc). These compounds are largely full agonists, which means that they will most likely have a greater effect on CB2 mediated apoptosis of T-cells. The person I talked to about this was very insistent that use of these compounds would severely fuck you up, for lack of a better term.
However, some research has determined that these drugs would be beneficial for pain, as well as fighting cancer.
http://www.ncbi.nlm.nih.gov/pubmed/17185040
I personally know of several different trials that are utilizing CB2-selective agonists for a variety of ailments, which to me, hints that these compounds are not as immunosupressive as my friend led me to believe.
Does anyone here have any insight to how detrimental these potent CB agonist could be for the immune system? Is it likely that use of these compounds could produce permanent immune system dysfunction through destruction of T-cells? I understand that I will most likely not get a definitive answer, I'm just looking for someone who has a better understanding of CB2 receptors and the immune system, as well as how 'delicate' the population of T-cells is (i.e. how much destruction of T-cells before noticeable impairments in immune function. For example, Parkinson's symptoms aren't exhibited until >70% neuron loss in the substantia nigra.)
Edit: I realize my example of Parkinson's is not exactly analogous, however, it highlights the issue of distinction between destruction of cells and measurable impairment.
